Volume 20, number 1
 Views: (Visited 230 times, 1 visits today)    PDF Downloads: 274

Kumar K. D, Vigneshwari J, Gnanasekaran A, Selvamani V, Senthilkumar P. K. Multipotential Secondary Metabolites from Nocardiopsis dassonovillei of Marine Actinomycetes and their In Silico Studies. Biosci Biotech Res Asia 2023;20(1).
Manuscript received on : 27-09-2022
Manuscript accepted on :  20-01-2023
Published online on:  08-02-2023

Plagiarism Check: Yes

Reviewed by: Dr. Rashmi Rekha Kumari

Second Review by: Dr. Sachchidanand Tewari

Final Approval by: Dr. Fernando José Cebola Lidon

How to Cite    |   Publication History    |   PlumX Article Matrix

Multipotential Secondary Metabolites from Nocardiopsis dassonovillei of Marine Actinomycetes and their In Silico studies

K. Dinesh Kumar1, J. Vigneshwari2, A. Gnanasekaran3, V. Selvamani1 and P. K. Senthilkumar1*

Department of Microbiology, Annamalai University, Annamalai Nagar, Tamil Nadu, India

Corresponding Author E-mail: drpks1980@gmail.com

DOI : http://dx.doi.org/10.13005/bbra/3079

ABSTRACT: Actinomycetes are one of the important secondary metabolite producers. Researchers focused on the exclusive marine areas for isolation and identification of marine actinomycetes. The present study focused on the isolation and identification of Nocardiopsis dassonovillei (ON627850) from TS Pettai region. The potential strainTSP1 showed effective antibacterial activity against Haemophilus influenza. TSP1 isolates showed IC50 value of 75.22 μg/ml effective antioxidant activity determined by DPPH assay. Cytotoxicity assay results were noted for the ethyl acetate extract of TSP1 screened against oral cancer cell lines (KB). The spectral characterization studies of UV, FT-IR and GC-MS results identified the compound 2,4-di-tert-butylphenol. The multi-potential 2,4-di-tert-butylphenol compound finally docked with KB cell lines protein for drug discoveries.

KEYWORDS: Actinomycetes; Cytotoxicity assay; DPPH, Drug; KB cell; Molecular Docking

Download this article as: 
Copy the following to cite this article:

Kumar K. D, Vigneshwari J, Gnanasekaran A, Selvamani V, Senthilkumar P. K. Multipotential Secondary Metabolites from Nocardiopsis dassonovillei of Marine Actinomycetes and their In Silico Studies. Biosci Biotech Res Asia 2023;20(1).

Copy the following to cite this URL:

Kumar K. D, Vigneshwari J, Gnanasekaran A, Selvamani V, Senthilkumar P. K. Multipotential Secondary Metabolites from Nocardiopsis dassonovillei of Marine Actinomycetes and their In Silico Studies. Biosci Biotech Res Asia 2023;20(1). Available from: https://bit.ly/3jHtaa8

Introduction

Marine microorganisms are presently attracting a lot of attention as a novel and prospective source of biologically active compounds 1. They produce a wide range of metabolites, some of which can be exploited in the creation of drugs 2. The 95% of actinomycetes are present in both environmental habitats, both aquatic and terrestrial 3,4. They are saprophytic, free-living bacteria that are a significant contributor to the manufacturing of antibiotics. They are crucial in the recycling of organic materials 5 Actinomycetes were extensively screened in marine plants, medicinal plants, sediments, and soil environments by recent researchers 6-7. Actinomycetes have long been known as major manufacturers of enzymes, antibiotics, amino acids, anti-cancer medications, anti-diabetic pharmaceuticals, anti-obesity treatments, and pharmaceutically and industrially essential compounds. Around 80% of all antibiotics produced by bacteria, including streptomyces, are produced by this organism. It is also capable of producing several active secondary metabolites 8. Secondary metabolites produced by actinomycetes continue to provide a chemically varied source for the discovery and development of pharmacological drugs as well as biochemical probes to investigate the mechanisms involved in human diseases 9.

Materials and Methods

Isolation of Actinomycetes

Marine sediment samples were collected from different sites of TS Pettai (Latitude 11.4110ºN, Longitude 79.7954ºE) Ponnanthittu (Latitude 11.483318ºN, Longitude 79.760164ºE) and Parangipettai (Latitude 11.49045ºN, Longitude 7976594ºE) at a depth of 10 cm, samples were taken 0.5 km from the coast. The sediments’ surface layers were removed, and the center part of each sediment, weighing approximately 0.5 kg, was aseptically transferred into polythene bag. These samples were allowed to air dry for one week after the pretreatment sediment samples were serially diluted 10-7 and aliquots (0.1 ml) plated on Starch Casein Agar (SCA) and Actinomycetes Isolation Agar (AIA) mixed with 50% sea water and 50% distilled water. After the sterilization add the (fluconazole 25μg/ml) to inhibit the fungal control of the petriplate. Plates were incubated for 7-10 days at 21 ºC. Subcultures of the isolated actinomycetes strains were stored at 4°C.

 Antagonistic Activity

The antagonistic activities of the isolated actinomycetes were tested against human pathogenic bacteria by cross streaking method and incubate the plates for 37ºC at 24 for hours. After the incubation period the actinomycetes strains inhibit the pathogenic bacteria. The best actinomycetes strains were chosen and further investigated.

 Identification of Actinomycetes

The potential actinomycetes strains were tested morphological, cultural, physiological and biochemical characteristics 10. The majority of marine actinomycetes produced unpigmented grey and white colonies. The spore chain and spore bearing hyphae morphology were observed and using high power optical microscope at x1000 magnification 11. Under a light microscope, the colors of the spore mass were analysed 12.

 Extraction of Bioactive Compounds

The antagonistic actinomycetes isolates were inoculated into starch casein broth and incubated at 28ºC in incubator shaker 250 rpm for seven days. The broths were filtered on Whatman No. 1 filter paper after incubation period and were centrifuged at 4000 rpm for 15 minutes to extract the bioactive compound. The supernatant were aseptically transferred into a conical flask and kept at 4ºC for further analysis. To the supernatant and an equal volume of each solvent (Viz., Methanol, Ethanol, Ethyl acetate, Acetone, Hexane and Chloroform) on 1:1dilution. The activity of the compounds produced from each solvent was evaluated against the test pathogens 13.

 Screening of Antibacterial Activity

The antibacterial activity of the actinomycetes isolates were evaluated against the bacterial Gram negative pathogens such as Escherichia coli, Klebsiella pnemoniae, Serritia marcescens, Salmonella typhi, Proteus mirabilis, and Gram positive pathogens such as Streptococcus pyogenes, Staphylococcus aureus, Enterococcus faecalis, Listeria monocytogenes, Haemophilus influenza. The different concentrations of 25 µl, 50 µl, 75 µl and 100 µl of crude extract were used. Chloramphenicol (10µg/ml) antibiotic used as a positive control and DMSO used as a negative control 14.

Determination of the Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)

The MICs were calculated using test organisms that demonstrated sensitivity to crude extracts using the broth microdilution technique. To allow for a 50% dilution after the inoculum, solvents, or antibiotic were added, the medium used in the plates was prepared at twice the final strength. All 96 wells were filled with a 100 µl volume of Muller Hinton broth that was doubled in strength before different antibiotic concentrations were added in decreasing order along the wells. Finally, the test organism suspension was added to each well in a 50 µl volume. After that, the plates were incubated at 37°C for 18-24 hours. Even as growth controls, the wells in columns 8 and 9 are kept at the positive (crude extracts) and negative (Test organisms) controls 15.

Antifouling Activity

Biofilm producing bacteria (1 mL of seawater) were incubated with conical flask of nutrient broth medium at 37 ºC for 24 hours. As an antifouling agent, about 0.1 g of the crude extract was added to the flask. After dying for 10 minutes with 0.4% crystal violet solution, the cover glass was cleaned with water, air dried, and observed under the microscope (OPTIKA microscopes, model: B-182, Italy). To compare, a control flask (without crude extract) was used 16.

 Antioxidant Activity

The DPPH test is widely used in natural product antioxidant research. This method’s simplicity and sensibility are among the factors. The idea behind this test is that an antioxidant is a hydrogen donor. It assesses chemicals that act as radical scavengers. The process by which DPPH takes hydrogen from an antioxidant is illustrated below. One of the few stable and easily obtained organic nitrogen radicals is DPPH. The reduction of DPPH in test samples reflects the antioxidant action. Due to its ease and precision, monitoring DPPH with a UV spectrometer has become the most popular technique. At 517 nm, DPPH has a significant absorption maximum (purple). When hydrogen from an antioxidant is absorbed, the colour changes from purple to yellow and DPPH is then produced. In terms of the quantity of hydrogen atoms absorbed, this reaction is stoichiometric. As a result, the reduction in UV absorption at 517 nm makes it simple to assess the antioxidant impact.

The 0.1 mM DPPH solution in methanol should be prepared in a hurry, and 100 μl of this solution should be added to 300 μl of the crude at various concentrations (500, 250, 100, 50, and 10 μg/mL). The mixes must be briskly mixed and let to stand for 30 minutes at room temperature. The absorbance at 517 nm must then be measured with a UV-VIS spectrophotometer. (Ascorbic acid can be used as the reference). Higher levels of free radical scavenging activity are shown by reaction mixtures with lower absorbance values. The following formula can be used to calculate the capability of scavenging the DPPH radical 17.

DPPH Scavenged (%) = (A con – A test / A con) × 100

A con – absorbance of the control reaction

A test – absorbance of the sample     

16S rRNA gene sequencing and phylogenetic analysis

Sequencing of the 16S rRNA gene showed some results. The 16S rRNA gene was sequenced using a PCR thermal cycler (Gene Amp PCR System 9700, Applied Biosystems). In order to get the closest match sequence, sequences were compared with the GenBank database using Blast N. The Pairwise alignment tool was used to align the sequences 18. A consensus sequence was created using the aligned sequence. The produced consensus sequence was utilised to perform BLAST in NCBI to find related sequences. MEGA software was used to create a phylogenetic tree using the top ten sequences from the hit table 19.

 SEM analysis

Streptomyces sp isolate TSP 1 was grown on Starch Casein Agar (SCA) media (28°C ± 1 for 7 days) for analysis using SEM.

GC-MS Analysis

The 8890 GC Agilent gas chromatography with front detector FID was used for the GC-MS study. The apparatus features a non-polar DB 35 – MS Capillary Standard column with measurements of 30 mm 0.25 mm ID 0.25 m film. Helium with a flow rate of 1.0 ml/min is the carrier gas utilised. The oven temperature was configured as follows, with the injector running at 250 °C: 15 minutes at 60 °C, followed by a 3 minute climb to 280 °C. The ratio of 1:100 was used to inject one microliter of extract in split mode into the GC column’s injection port. The GC peak regions determined the sample’s composition as a percentage. Willey and NIST libraries, as well as a comparison of their retention indices, were used to identify the components. After comparison with those in the computer library (NIST and Willey) connected to the GC-MS instrument, the components were identified, and the findings were tallied.

 UV- Vis and FT-IR Analysis

The UV-spectra of Nocardiopsis dassonovillei obtained from this study were subjected to comparison of general pattern maximum absorbance peaks and range of wave length. Using UV-visible spectrophotometer Shimadzu – UV 1800, the UV region (200-800 nm) of each active extract was measured. The FTIR spectra of each active extract was then identified using a Shimadzu IR-470 plus. Moreover, the spectra were scanned between 400 and 4000 cm-1, and the results were shown as Transmittance (%) vs wavelength (cm-1) 20,21.

 Cytotoxic Activity [2,4-Di-tert-butylphenol (MTT Assay)]

The human oral cancer cell line NF-kB used for the study. The cell line was cultured in DMEM (Dulbecco’s Modified Eagle Media) medium with 10% FBS (Fetal Bovine Serum) supplementation at 37°C in an incubator with 5% CO2. To avoid bacterial contamination, antibiotics penicillin (100µg/mL) and streptomycin (100µg/mL) were added to the medium 22.

Molecular Docking

The compounds from marine Nocardiopsis dassonovillei were selected as ligands based on anticancer activity reported previously. The compound 2, 4-Di-tert-butylphenol was isolated from marine-derived Streptomyces sp and has been shown to possess significant cytotoxicity against oral cancer cell lines (KB cell).

Results and Discussion

Actinomycetes from Marine Sediment Samples

As other researchers have documented the presence of actinomycetes in coastal and marine sediment. Several quantities of actinomycetes were also identified in the current investigation. The 3 different isolates in all were found in the various samples of marine sediment (Table 1 & Figure 1). The coastal mangrove sediments yielded the largest amount of isolates. According to other reports that have documented the presence of actinomycetes in the sediment of marine and estuarine settings, a significant portion of actinomycetes were isolated in the present research 24,25. The sediment samples are taken during tidal waves that are between 4 and 6 meters in depth. A minimum of 1.1×103/g and a maximum of 1.5 x 106 CFU of actinomycetes were found in different sediments 26.

Table 1: Morphological characterization of actinomycetes.

Click here to view  Table

 

Figure 1: Isolation of actinomycetes.

Click here to view figure

Screening of Antagonistic Activity

 The potential strains inhibited the growth of Gram negative pathogens such as Escherichia coli, Klebsiella pnemoniae, Serritia marcescens, Salmonella typhi, Proteus mirabilis, and Gram positive pathogens such as Streptococcus pyogenes, Staphylococcus aureus, Enterococcus faecalis, Listeria monocytogenes and Haemophilus influenza. The growth inhibition zone was around 6 – 30 mm in diameter on average. The diameter of the zone of growth inhibition produced by it reached 30 mm for H. influenza. 

Identification of actinomycetes

Identification of actinomycetes using molecular techniques was found to be faster and less difficult than standard biochemical procedures. All of the actinomycetes isolates are members of the genus Streptomyces, according to the results of the direct sequencing of purified 16S rRNA. All of the isolates have spore chains of three or more, and results obtained with a research microscope at 100X revealed that they are all non-motile and have such spore chains. Streptomyces is a good source of physiologically active secondary metabolites. The Nocardiopsis dassonovillei (Accession number ON627850) is a moderately marine actinomycetes strain isolated and identified from the TS Pettai, Ponnanthittu and Parangipettai marine sediment areas based on morphological, microscopical and 16S rRNA molecular profiling. 

Extraction of actinomycetes

The six different solvent extracts were used to assess the isolates antimicrobial activity ethyl acetate extract provided the largest inhibitory zone against all the pathogens tested, followed by ethanol, methanol, hexane, acetone and chloroform extracts. The strain TSP1’s ethyl acetate extract had the highest level of effectiveness against Haemophilus influenza (30 mm) and was followed by Salmonella typhi (27mm).

 Screening of Antibacterial Activity

The crude extract shows the antibacterial activity against Gram positive bacteria such as Haemophilus influenza (30 mm) and gram negative bacteria such as Salmonella typhi (27mm)  at 100 μl of concentration mentioned above (Table 2) (Figure 2). The isolates TSP1 showed a broad spectrum of antibacterial activity against the variety of clinical bacterial pathogens concluded by antagonistic activity, well diffusion method, MIC and MBC. TSP1 ethyl acetate crude extract showed maximum zone of inhibition against Haemophilus influenza (30 mm) at 100 μl concentration respectively.

Table 2: The antibacterial activity for the crude extract of actinomycetes isolates against some bacterial pathogens

Pathogens

Zone of inhibition (mm)

 

25 μl

50 μl

75 μl

100 μl

+ ve control

-ve control

E. coli

17±1.53

19±1.53

22±0.58

23±1.15

16±1.00

K. pnemoniae

18±0.58

22±0.58

24±1.53

26±0.58

17±1.53

S. marcescens

17±1.53

21±1.00

22±0.58

24±1.53

26±0.58

S. typhi

21±1.00

23±1.15

25±1.00

27±1.00

19±1.53

P. mirabilis

14±1.00

16±1.00

19±1.53

21±1.00

15±0.58

S. aureus

16±1.00

18±0.58

21±1.00

22±0.58

15±0.58

S. pyogenes

19±1.53

21±1.00

23±1.15

24±1.53

16±1.00

E. faecalis

21±1.00

23±1.15

25±1.00

26±0.58

17±1.53

L. monocytogenes

22±0.58

24±1.53

26±0.58

29±1.00

18±0.58

H. influenza

23±1.15

25±1.00

27±1.00

30±1.00

19±1.53

 

Figure 2: Antibacterial activity of crude extracts.

Click here to view figure

Determination of MIC and MBC

As a result, the MIC wells could be distinguished visually with clarity. The extract’s minimum inhibitory concentration (MIC), which is the concentration at which the growth of the test organisms is inhibited, were calculated (Figure 3). Following a procedure, the minimum bactericidal concentration (MBC) was measured from the MIC plate (Figure 4). It is described as the lowest concentration of an antibiotic that, when used in defined in vitro conditions, decreases the number of organisms in a medium containing a certain inoculum of bacteria by 99.9 percent in a specified amount of time. It was measured by inoculating broths in the MIC range into a nutrient agar medium that was free of drugs. The antimicrobial concentration at which no growth was seen after a 48-hour incubation period was chosen as the MBC. The MIC results conclude and compare with other solvents finally the ethyl acetate will give the best minimum concentration are shown in (Table 3).

Figure 3: MIC of different extracts of Nocardiopsis dassonvillei against Haemophilus influenza ATCC 49247

Click here to view figure

 

Figure 4: MBC of different extracts of Nocardiopsis dassonvillei against Haemophilus influenza ATCC 49247.

Click here to view figure

Table 3: Minimum inhibitory concentration and minimum bactericidal concentration of crude extracts of Nocardiopsis dassonoveilli

Extract Code

Test organisms

Gram reaction

MIC (mg/ml)

MBC (mg/ml)

TSP1

Echerichia coli

10

20

 

Klebsiella pnemoniae

15

30

 

Serratia marcescens

20

40

 

Salmonella typhi

10

20

 

Proteus mirabilis

40

60

 

Staphylococcus aureus

+

15

30

 

Streptococcus pyogenes

+

20

40

 

Enterococcus faecalis

+

40

60

 

Listeria monocytogenes

+

05

10

Antifouling activity of Nocardiopsis dassonovillei

The Nocadiopsis dassonovillei crude extract inhibits the production of bacterial biofilms, as shown in Figure. The crude extract served as an anti-biofouling agent and decreased the density of bacterial cells. The results of the current study suggested that the marine Nocardiopsis dassonovillei crude extract may be a source for the synthesis of environmentally beneficial antifouling chemicals, which might be a better alternative to the pollution-causing synthetic antifoulants. This finding was consistent with research on the antifouling properties of Nocadiopsis dassonovillei, which decreased the growth of biofilm on glass.

Antioxidant activity

Free radicals are groupings that contain a single pair of electrons and have negative effects to living organisms by creating an oxidation mechanism that results in a deadly consequence. The antioxidants are the substance that inhibits this type of free radical from causing an oxidation process mentioned in (Tables 4, 5 and 6 & Figures 5, and 6). The TSP isolate has produced the dose IC50 Value of the tested sample: 75.22 μg/ml (Figure 7). . Antioxidant studies revealed the TSP1 ethyl acetate crude extract has antioxidant properties by inhibition of free radical scavenging 27.

Table 4: OD Value at 517 nm

S. No

Tested sample concentration (μg/ml)

OD Value at 517 nm (in triplicates)

  1.  

Control

0.724

0.756

0.971

  1.  

500 μg/ml

0.134

0.137

0.138

  1.  

250 μg/ml

0.138

0.152

0.160

  1.  

100 μg/ml

0.163

0.173

0.165

  1.  

50 μg/ml

0.180

0.185

0.189

  1.  

10 μg/ml

0.199

0.213

0.228

  1.  

Ascorbic acid

0.08

0.11

0.12

Table 5: Percentage of inhibition

S. No

Tested sample concentration (μg/ml)

Percentage  of inhibition    (in triplicates)

 

 

Mean value (%)

 

  1.  

Ascorbic acid

90.20

86.53

85.31

87.35

  1.  

500 μg/ml

83.59

83.23

83.10

83.31

  1.  

250 μg/ml

83.10

81.39

80.41

81.64

  1.  

100 μg/ml

80.04

78.82

79.80

79.55

  1.  

50 μg/ml

77.96

77.35

76.86

77.39

  1.  

10 μg/ml

75.64

73.92

72.09

73.88

Table 6: IC50 Value of tested sample: 75.22 μg/ml

log(inhibitor) vs. normalized response — Variable slope

 

 

Best-fit values

 

LogIC50

1.876

HillSlope

-1.535

IC50

75.22

Std. Error

LogIC50

0.05021

HillSlope

0.2854

95% Confidence Intervals

 

 

LogIC50

1.768 to 1.985

HillSlope

-2.152 to -0.9186

IC50

58.59 to 96.56

Goodness of Fit

 

 

Degrees of Freedom

13

R square

0.9233

Absolute Sum of Squares

1510

Sy.x

10.78

Number of points

 

 

Analyzed

3

15

 

Figure 5: 2,4 Di-tert-butylphenol μg/ml

Click here to view figure

 

Figure 6: 2,4 Di-tert-butylphenol μg/ml range

Click here to view figure

 

Figure 7: IC50 Value of tested sample: 75.22 μg/ml

Click here to view figure

16s rRNA gene sequencing and phylogenetic analysis

It was amplified and sequenced to study the 16S rRNA gene of Streptomyces sp. A stretch of 1379 nucleotides made up of TSP1 complete 16S rRNA gene sequence, and the nucleotide sequence has been uploaded to GenBank (Accession number ON627850). The phylogenetic tree of Streptomyces sp. TSP 1 was built using the 16S rRNA gene sequence Figure 8. The strain’s phylogenetic location was within a cluster that also contained Nocardiopsis dassonovillei (ON627850). TSP exhibited a 78% sequence similarity with Nocardiopsis dassonovillei (ON627850) and was presented as a single branch. 

Figure 8: Phylogenetic tree of Nocardiopsis dassonoveilli

Click here to view figure

SEM analysis

In SEM analysis, the TSP1 potential strain showing 2 µm in size and rod shape observed under the Scanning electron microscope (Figure 9 & 10).

Figure 9: A Microscope was used to examine the colony morphology.

Click here to view figure

 

Figure 10: A scanning electron microscope was used to examine the spore ornamentation and chain morphology.

Click here to view figure

Gas Chromatography and Mass Spectrometry

The structure of compound TSP1 was further elucidated by GC-MS which exhibited molecular adduct ion peak at m/z 16.052 (Figure 11 and 12). The mass spectrum of compound TSP1 was found to be identical to 2,4 Di-tert-butylphenol and the structure of the compound was also confirmed in the GC-MS library.

Figure 11: GC-MS analysis peak at 16.052

Click here to view figure

 

Figure 12 : GC-MS analysis (2, 4 Di-tert-butylphenol).

Click here to view figure

UV Visible analysis

Studies on UV-visible absorption were carried out with a Shimadzu spectrophotometer (UV-1800) and matched quartz cuvettes with a 1 cm path length. Using the UV-Vis spectrum between 200 and 800 nm, the TSP compound was observed. In (Figure 13) the pointed adsorption peak is displayed.

Figure 13: UV-Visible analysis.

Click here to view figure

FT-IR analysis

The crude extracts of the TSP isolates were analyzed using GC-MS. The chemical compositions of the extracts were ascertained using GC-MS. The chemical compositions of the extracts were determined using elemental and functional group analysis data, as well as FT-IR investigations. The FT-IR spectrum (Figure 14) contained bands at 3446 cm-1, 2043 cm-1, 1635 cm-1, 1414 cm-1, 1103 cm-1 and 562 cm-1. A phenol belonging to the 2,4-di-tert-butylphenol class has two tert-butyl substituents at positions 2 and 4. All these indicated the presence of bioactive compounds which include n GC-MS. The multi-potential TSP1 ethyl acetate extracts spectral studies UV – Visible, FT-IR and GC-MS results identified as component 2,4-di-tert-butylphenol from Nocardiopsis dassonovillei is more effective against antimicrobial and anticancer activities


Figure 14: FT-IR analysis

Click here to view figure

Microscopic analysis and MTT assay

Cancer cells were seeded in 96-well plates at a density of 5000 cells per well. The attached cells were incubated for 24 hours and treated with different concentrations of 2, 4-Di-tert-butylphenol (20 & 25 µM/ml) of DMEM media and were then incubated for 24 and 48 hours. The cells were examined under a microscope for morphological changes. By using 20 µl of MTT solution (5 mg/ml) was used to measure the cell viability. The plates were incubated for 4 hours at 37°C. The formazan crystals were dissolved in DMSO, and the soluble formazan product was measured spectrophotometrically at 575 nm using an ELISA reader are shown in (Figure 15).

Figure 15: Morphological changes of NF-kB cells after treatment by the 2,4-Di-tert-butylphenol.

Click here to view figure

Molecular Docking analysis

The compound 2, 4-Di-tert-butylphenol was selected and docked with cancer target proteins and the least binding energy was calculated. Amino acids of NF-kB protein involved in the interaction with 2,4-Di-tert-butylphenol. The ligand 2,4-Di-tertbutylphenol interacted with the following amino acids ASP 534, CYS 533, GLY 409, ARG 408, GLY 407, LEU 406, VAL 414, LYS 429, ALA 427, MET 469, LEU 471, LEU 472, GLY 475, SER 476, GLN 479, LEU 522, ASN 520 and ASP 519. Among the ligands tested 2, 4-Di-tert-butylphenol was very effective in interacting with human oral cancer cell lines (KB Cell) 23. Actinomycetes create a wide range of organic compounds with a variety of biological functions, including anti-tumor effects (Table 7 and 8 and Figure 16). The present in silico studies analysed the isolated compound 2,4- di-tert-butylphenol are docked with human oral cancer cell lines (KB cell) proteins 28.   

Table 7: Summary of molecular docking results of ligands with cancer drug target protein NF-kB 

Ligand

Target Protein

Pdb ID

Binding Energy

Amino Acids

2,4-Di-tert-butylphenol

NF-Kb

Pdb4DN5

-6.8

ASP 534, CYS 533, GLY 409, ARG 408, GLY 407, LEU 406, VAL 414, LYS 429, ALA 427, MET 469, LEU 471, LEU 472, GLY 475, SER 476, GLN 479, LEU 522, ASN 520 and ASP 519

 Table 8: Molecular Docking score value

Vina score

Cavity Size

Center

 

Size

X

Y

Z

X

Y

Z

-6.8

19984

-11

41

-13

35

35

35

-5.3

1317

-5

41

-12

18

18

18

-5.2

450

-6

32

9

18

24

18

-5

422

-3

51

-34

18

18

18

-4.8

226

-10

4

-8

18

18

18

 


 Figure 16: Molecular Docking of 2,4-Di-tert-butylphenol interact with oral cancer cell line.

Click here to view figure

Conclusion

In recent years marine Streptomyces sp have been a rich source of novel and therapeutically active compounds. Actinomycetes have been extensively explored over the past 30 years, yet they have shown to be promising producers of new bioactive compounds. The secondary metabolite trends of an actinobacterial strain can change when heavy metals are added to the fermentation medium, as demonstrated by two chemical and pharmacological screening techniques. This research developed a rapid, accessible method for identifying secondary metabolites of the sort that are completely absent from regular culture when grown under good conditions. The current work is a small attempt to link in silico and in vitro data with potential screening of compounds from a library for drug development.

Acknowledgement

The authors thank to Funding agency grateful thanks to Rashtriya Uchchatar Shiksha Abhiyan (RUSA 2.0 /R&I/ Field 1) for granting support, encouragement for providing the lab facilities and consumables for this research work and support for this project.

Conflicts of Interest

All the authors to declare there are no conflicts of interest in this article to publish. 

References

  1. Rosa, S. D., Mitova, M., Caro, S. D., & Tommonaro, G. New peptide from a bacterium associated with marine sponge Ircinia muscarum. In Biodiversity. 2002 ., 335-340.
    CrossRef
  2. Pietra, F. Secondary metabolites from marine microorganisms: bacteria, protozoa, algae and fungi. Achievements and prospects. Natural product reports., 1997.,14: 453-464.
    CrossRef
  3. Kamil, I., Talha, G., Fadime, Z. K., & Elif, C.Molecular identification of different actinomycetes isolated from East Black Sea region plateau soil by 16S rDNA gene sequencing. African Journal of Microbiology Research., 2014., 89: 878-887.
    CrossRef
  4. Macagnan, D., Romeiro, R. D. S., de Souza, J. T., & Pomella, A. W. Isolation of actinomycetes and endospore-forming bacteria from the cacao pod surface and their antagonistic activity against the witches’ broom and black pod pathogens. Phytoparasitica, 2006., 34: 122-132.
    CrossRef
  5. Lacey, J. Ecology of actinomycetes in fodders and related substrates. Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1978
  6. Williams, S. T. Streptomycetes in the soil ecosystem. Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1978
  7. Devi, C. S. Novel anticancer compounds from marine actinomycetes: a review. 2011
  8. Rana, S., & Salam, M. D. Antimicrobial potential of actinomycetes isolated from soil samples of Punjab, India. J Microbiol Exp, 2014., 1: 00010.
    CrossRef
  9. Imada, C. Enzyme inhibitors and other bioactive compounds from marine actinomycetes. Antonie Van Leeuwenhoek, 2005.,87: 59-63.
    CrossRef
  10. Shirling, E. T., & Gottlieb, D. Methods for characterization of Streptomyces species. International journal of systematic bacteriology, 1966.,16: 313-340.
    CrossRef
  11. Williams, S. T. Genus Streptomyces Waksman and Henrici 1943. Bergey’s Manual of Systematic Bacteriology., 1989., 4: 2452-2492.
  12. Pridham, T. G. Color and Streptomycetes: report of an international workshop on determination of color of Streptomycetes. Applied Microbiology., 1965., 13: 43-61.
    CrossRef
  13. Sambamurthy, K., & Ellaiah, P. A new Streptomycete producing neomycin (B&C) complex-S. marinensis (part I). Hindustan antibiotics bulletin, 1974., 17: 24-28.
  14. Daoud, A., Malika, D., Bakari, S., Hfaiedh, N., Mnafgui, K., Kadri, A., & Gharsallah, N. Assessment of polyphenol composition, antioxidant and antimicrobial properties of various extracts of Date Palm Pollen (DPP) from two Tunisian cultivars. Arabian Journal of Chemistry, 2019., 12: 3075-3086.
    CrossRef
  15. Sibanda, T., Mabinya, L. V., Mazomba, N., Akinpelu, D. A., Bernard, K., Olaniran, A. O., & Okoh, A. I. Antibiotic producing potentials of three freshwater actinomycetes isolated from the Eastern Cape Province of South Africa. International journal of molecular sciences, 2010., 11: 2612-2623.
    CrossRef
  16. Bavya, M., Mohanapriya, P., Pazhanimurugan, R., & Balagurunathan, R. Potential bioactive compound from marine actinomycetes against biofouling bacteria. 2011
  17. Silva, B. A., Ferreres, F., Malva, J. O., & Dias, A. C. Phytochemical and antioxidant characterization of Hypericum perforatum alcoholic extracts. Food chemistry, 2005., 90: 157-167.
    CrossRef
  18. Hall, T. A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. In Nucleic acids symposium series[London]: Information Retrieval Ltd., c1979-c2000. ., 1999 ., 41: 95-98.
  19. Madden T. The BLAST Sequence Analysis Tool. 2002 Oct 9 [Updated 2003 Aug 13]. In: McEntyre J, Ostell J, editors. The NCBI Handbook [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2002-. Chapter 16. Available from: http://www.ncbi.nlm.nih.gov/books/NBK21097.
  20. Şahin, N., & Uğur, A. Investigation of the antimicrobial activity of some Streptomyces isolates. Turkish Journal of Biology, 2003., 27: 79-84.
  21. Augustine, S. K., Bhavsar, S. P., & Kapadnis, B. P. A non-polyene antifungal antibiotic fromStreptomyces albidoflavus PU 23. Journal of Biosciences, 2005., 30: 201-211.
    CrossRef
  22. Martin, G. D., Tan, L. T., Jensen, P. R., Dimayuga, R. E., Fairchild, C. R., Raventos-Suarez, C., & Fenical, W. Marmycins A and B, cytotoxic pentacyclic C-glycosides from a marine sediment-derived actinomycete related to the genus Streptomyces. Journal of natural products, 2007., 70: 1406-1409.
    CrossRef
  23. Olano, C., Méndez, C., & Salas, J. A.Antitumor compounds from marine actinomycetes. Marine drugs, 2009., 7: 210-248.
    CrossRef
  24. Vikineswary, S., Nadaraj, P., Wong, W. H., & Balabaskaran, S. Actinomycetes from a tropical mangrove ecosystem- Antifungal activity of selected strains. Asia-Pacific Journal of Molecular Biology and Biotechnology, 1997., 5: 81-86.
  25. Goodfellow, M., Ferguson, E. V., & Sanglier, J. J. Numerical classification and identification of Streptomyces species—a review. Gene, 1992., 115(1-2), 225-233.
    CrossRef
  26. Manfio, G. P. Towards minimal standards for the description of Streptomyces species. Bioteckhnologia, 1995., 8: 228-237.
  27. Jensen, P. R., Dwight, R. Y. A. N., & Fenical, W. I. L. L. I. A. M. Distribution of actinomycetes in near-shore tropical marine sediments. Applied and environmental microbiology, 1991., 57: 1102-1108.
    CrossRef
  28. Jensen, P. R., & Fenical, W. Marine microorganisms and drug discovery: current status and future potential. Drugs from the Sea, 2000., 6-29.
    CrossRef
(Visited 230 times, 1 visits today)

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.